Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Abroad (travel likely)Recruiting

Conditions

Healthy · Fatty Liver · MASLD · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · Obesity and Obesity-related Medical Conditions

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London, London, United Kingdom
Contact: Study coordinator (James Rickard) · j.rickard@richmondpharmacology.com
Contact: Principal Investigator (Jorg Taubel, MD FFPM)

Study leads

Jorg Taubel, MD
Principal Investigator
Richmond Pharmacology Limited

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Imaging Techniques in MRI

Cardiac Risk Factors · Healthy · Healthy Volunteers

Abroad (travel likely)Recruiting

Bethesda, United States

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy

Autophagy · Healthy Aging

Abroad (travel likely)Recruiting

Canfield, United States

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Healthy Volunteers · Alcohol Use Disorder (AUD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States